Home » Markets

Vodafone Group (LON:VOD) Stock Rating Reaffirmed by Beaufort Securities

Vodafone Group (LON:VOD)‘s stock had its “buy” rating reissued by Beaufort Securities in a research report issued on Tuesday, November 14th. They currently have a GBX 260 ($3.48) price target on the cell phone carrier’s stock. Beaufort Securities’ price target would suggest a potential upside of 15.57% from the stock’s previous close. VOD has been the subject of a number of other research reports. Goldman Sachs Group set a GBX 285 ($3.82) price objective on Vodafone Group and gave the company a “buy”... 
 

ADMA Biologics (NASDAQ:ADMA) Upgraded to Outperform by Raymond James Financial

Raymond James Financial upgraded shares of ADMA Biologics (NASDAQ:ADMA) from a market perform rating to an outperform rating in a report issued on Tuesday, November 14th, MarketBeat reports. They currently have $5.00 price objective on the biotechnology company’s stock. Separately, ValuEngine lowered ADMA Biologics from a sell rating to a strong sell rating in a research report on Friday, September 1st. Shares of ADMA Biologics (NASDAQ ADMA) traded up $0.08 during midday trading on Tuesday, hitting $2.98. The stock had a trading volume of... 
 

Signet Jewelers (NYSE:SIG) Price Target Increased to $72.00 by Analysts at Buckingham Research

Signet Jewelers (NYSE:SIG) had its price target boosted by Buckingham Research from $55.00 to $72.00 in a research report issued on Tuesday, November 14th. The firm currently has a “neutral” rating on the stock. Buckingham Research’s price target would suggest a potential upside of 38.49% from the stock’s previous close. SIG has been the subject of a number of other research reports. Zacks Investment Research upgraded Signet Jewelers from a “hold” rating to a “buy” rating and set a $71.00 price objective... 
 

IHS Markit (NASDAQ:INFO) PT Raised to $48.00

IHS Markit (NASDAQ:INFO) had its price target boosted by SunTrust Banks to $48.00 in a research report issued on Tuesday, November 14th. The firm currently has a “hold” rating on the business services provider’s stock. SunTrust Banks’ price target would suggest a potential upside of 7.36% from the stock’s previous close. INFO has been the subject of a number of other research reports. Zacks Investment Research lowered IHS Markit from a “hold” rating to a “sell” rating in a research report on... 
 

Redhill Biopharma (NASDAQ:RDHL) Price Target Cut to $20.00 by Analysts at Roth Capital

Redhill Biopharma (NASDAQ:RDHL) had its price objective cut by Roth Capital from $27.00 to $20.00 in a report issued on Tuesday, November 14th. They currently have a buy rating on the biotechnology company’s stock. RDHL has been the subject of a number of other research reports. HC Wainwright set a $33.00 price objective on Redhill Biopharma and gave the company a buy rating in a research report on Wednesday, July 26th. Zacks Investment Research upgraded Redhill Biopharma from a sell rating to a hold rating in a research report on Wednesday,... 
 

Superior Industries International (NYSE:SUP) Lowered to Strong Sell at Zacks Investment Research

Zacks Investment Research cut shares of Superior Industries International (NYSE:SUP) from a hold rating to a strong sell rating in a report issued on Tuesday, November 14th. According to Zacks, “Superior Industries’ reported adjusted loss of 2 cents per share in third-quarter 2017. The Zacks Consensus Estimate for earnings was 36 cents. However, the revenues came in higher than expected. The company has underperformed the industry it belongs to in the last three months. Rising capital expenditure and operating inefficiencies and changing... 
 

Shire (NASDAQ:SHPG) Stock Rating Upgraded by Liberum Capital

Shire (NASDAQ:SHPG) was upgraded by Liberum Capital from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday, November 14th. Other analysts also recently issued research reports about the stock. Cantor Fitzgerald restated a “buy” rating and set a $222.00 price target on shares of Shire in a report on Monday, August 21st. BTIG Research restated a “buy” rating and set a $242.00 price target on shares of Shire in a report on Monday, July 17th. Royal Bank Of Canada set a $213.00... 
 

Valero Energy (NYSE:VLO) Stock Rating Reaffirmed by Scotiabank

Scotiabank reissued their buy rating on shares of Valero Energy (NYSE:VLO) in a research report sent to investors on Tuesday, November 14th. They currently have a $84.00 target price on the oil and gas company’s stock. Several other analysts have also issued reports on the company. Cowen reiterated a buy rating and set a $90.00 target price on shares of Valero Energy in a report on Friday, November 3rd. Evercore ISI upgraded Valero Energy from an in-line rating to an outperform rating in a report on Thursday, November 2nd. Zacks Investment... 
 

Best Buy (NYSE:BBY) Rating Increased to Hold at Zacks Investment Research

Best Buy (NYSE:BBY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday, November 14th. According to Zacks, “Best Buy has exhibited a bullish run in the index and outpaced the industry in a year owing to strategic efforts, sturdy online sales growth and solid earnings history. The company is making extensive investments to upgrade operations with special focus on developing omni-channel capabilities and strengthening partnership with vendors. Moreover,... 
 

Air Products & Chemicals (APD) Lifted to Buy at HSBC

HSBC upgraded shares of Air Products & Chemicals (NYSE:APD) from a hold rating to a buy rating in a report issued on Tuesday, November 14th. Several other research analysts have also issued reports on APD. Credit Suisse Group restated an outperform rating and set a $158.00 target price (up previously from $153.00) on shares of Air Products & Chemicals in a research report on Wednesday, August 2nd. Deutsche Bank boosted their target price on Air Products & Chemicals from $160.00 to $168.00 and gave the company a hold rating in a research... 
 

Aecom (ACM) Receives Buy Rating from UBS

UBS reissued their buy rating on shares of Aecom (NYSE:ACM) in a research note issued to investors on Tuesday, November 14th, www.benzinga.com reports. UBS currently has a $4.00 target price on the construction company’s stock, down from their previous target price of $40.00. Several other equities analysts have also weighed in on ACM. Citigroup restated a buy rating and set a $40.00 price objective (down previously from $45.00) on shares of Aecom in a research report on Tuesday, July 18th. Zacks Investment Research lowered shares of Aecom... 
 

B. Riley Analysts Give Agree Realty (ADC) a $58.00 Price Target

Agree Realty (NYSE:ADC) has been given a $58.00 price objective by research analysts at B. Riley in a report released on Tuesday, November 14th. The brokerage currently has a “buy” rating on the real estate investment trust’s stock. B. Riley’s target price would suggest a potential upside of 17.20% from the company’s current price. ADC has been the subject of a number of other research reports. Zacks Investment Research upgraded shares of Agree Realty from a “hold” rating to a “buy” rating and... 
 

Aecom (ACM) Given “Hold” Rating at DA Davidson

Aecom (NYSE:ACM)‘s stock had its “hold” rating reaffirmed by stock analysts at DA Davidson in a research note issued to investors on Tuesday, November 14th. They currently have a $39.00 target price on the construction company’s stock. DA Davidson’s target price points to a potential upside of 3.48% from the stock’s current price. DA Davidson also issued estimates for Aecom’s Q1 2018 earnings at $0.56 EPS, Q2 2018 earnings at $0.66 EPS, Q3 2018 earnings at $0.74 EPS, Q4 2018 earnings at $0.74 EPS, FY2018... 
 

Arista Networks (ANET) Earns Market Perform Rating from Analysts at Wells Fargo & Company

Wells Fargo & Company started coverage on shares of Arista Networks (NYSE:ANET) in a report issued on Tuesday, November 14th, MarketBeat.com reports. The brokerage issued a market perform rating and a $235.00 target price on the technology company’s stock. Several other analysts also recently weighed in on the stock. BidaskClub raised shares of Arista Networks from a buy rating to a strong-buy rating in a research note on Tuesday, October 31st. Royal Bank Of Canada raised shares of Arista Networks from a sector perform rating to an outperform... 
 

Q2 (QTWO) Upgraded at BidaskClub

Q2 (NYSE:QTWO) was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Tuesday, November 14th. Several other brokerages have also commented on QTWO. KeyCorp reissued a “hold” rating on shares of Q2 in a research note on Wednesday, September 13th. Zacks Investment Research lowered Q2 from a “hold” rating to a “sell” rating in a research note on Wednesday, October 4th. BTIG Research restated a “buy” rating and set a $47.00 price objective... 
 

Blackline (NASDAQ:BL) Upgraded to Buy at BidaskClub

Blackline (NASDAQ:BL) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued on Tuesday, November 14th. A number of other research firms also recently issued reports on BL. SunTrust Banks reaffirmed a “buy” rating and issued a $42.00 price objective on shares of Blackline in a research note on Friday, November 3rd. KeyCorp reaffirmed a “buy” rating and issued a $39.00 price objective on shares of Blackline in a research note on Sunday, October... 
 

RPC Group (LON:RPC) Receives “Add” Rating from Numis Securities

RPC Group (LON:RPC)‘s stock had its “add” rating reaffirmed by investment analysts at Numis Securities in a research report issued on Tuesday, November 14th. They currently have a GBX 1,130 ($15.13) price objective on the stock. Numis Securities’ price objective suggests a potential upside of 23.94% from the stock’s previous close. A number of other research analysts also recently commented on RPC. J P Morgan Chase & Co reaffirmed an “overweight” rating and set a GBX 1,250 ($16.74) price objective... 
 

Loxo Oncology (NASDAQ:LOXO) Upgraded to Strong-Buy by Ifs Securities

Loxo Oncology (NASDAQ:LOXO) was upgraded by investment analysts at Ifs Securities from an “outperform” rating to a “strong-buy” rating in a research report issued on Tuesday, November 14th. A number of other research analysts also recently commented on LOXO. Citigroup reaffirmed a “buy” rating and set a $112.00 price objective (up from $86.00) on shares of Loxo Oncology in a research report on Friday, October 20th. Morgan Stanley reaffirmed an “overweight” rating and set a $103.00 price objective... 
 

Marathon Petroleum (NYSE:MPC) PT Raised to $76.00 at Barclays

Marathon Petroleum (NYSE:MPC) had its price objective hoisted by Barclays from $63.00 to $76.00 in a research report report published on Tuesday, November 14th. They currently have an overweight rating on the oil and gas company’s stock. Several other analysts also recently commented on MPC. Zacks Investment Research downgraded shares of Marathon Petroleum from a hold rating to a sell rating in a research report on Monday, July 17th. Jefferies Group reissued a buy rating and issued a $54.83 target price (down from $65.00) on shares of Marathon... 
 

Zacks Investment Research Downgrades ViaSat (VSAT) to Hold

ViaSat (NASDAQ:VSAT) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research report issued on Tuesday, November 14th. According to Zacks, “ViaSat’s second-quarter fiscal 2018 adjusted earnings beat the Zacks Consensus Estimate by a whopping 250% but fell year over year, hurt by escalating research and development costs, and costs related to the ViaSat-2 service launch activities. High R&D and ramp-up costs remain a major headwind to the company’s margins... 
 

Ranger Energy Services (NYSE:RNGR) Given New $12.00 Price Target at Barclays

Ranger Energy Services (NYSE:RNGR) had its price objective cut by investment analysts at Barclays from $16.00 to $12.00 in a research report issued on Tuesday, November 14th. The brokerage currently has an “equal weight” rating on the stock. Barclays’ price objective suggests a potential upside of 26.72% from the stock’s previous close. Several other analysts also recently commented on RNGR. Evercore ISI initiated coverage on shares of Ranger Energy Services in a research report on Tuesday, September 5th. They issued an... 
 

Kronos Worldwide (NYSE:KRO) Price Target Increased to $24.00 by Analysts at Barclays

Kronos Worldwide (NYSE:KRO) had its price objective hoisted by Barclays from $17.00 to $24.00 in a research report report published on Tuesday, November 14th. They currently have an underweight rating on the specialty chemicals company’s stock. Several other analysts also recently commented on KRO. BidaskClub downgraded shares of Kronos Worldwide from a strong-buy rating to a buy rating in a research report on Wednesday, July 19th. Zacks Investment Research raised shares of Kronos Worldwide from a hold rating to a strong-buy rating and set... 
 

Barclays Increases Forterra (NASDAQ:FRTA) Price Target to $7.00

Forterra (NASDAQ:FRTA) had its price objective hoisted by Barclays from $4.00 to $7.00 in a research report report published on Tuesday, November 14th. They currently have an equal weight rating on the construction company’s stock. A number of other research analysts also recently commented on FRTA. Zacks Investment Research raised shares of Forterra from a sell rating to a hold rating in a research report on Thursday, July 20th. ValuEngine downgraded shares of Forterra from a buy rating to a hold rating in a research report on Thursday, July... 
 

Bristow Group (NYSE:BRS) Price Target Increased to $16.00 by Analysts at Barclays

Bristow Group (NYSE:BRS) had its price objective upped by investment analysts at Barclays from $10.00 to $16.00 in a research report issued on Tuesday, November 14th. The brokerage currently has an “equal weight” rating on the oil and gas company’s stock. Barclays’ price objective suggests a potential upside of 9.07% from the stock’s previous close. Several other analysts also recently commented on BRS. BidaskClub raised shares of Bristow Group from a “sell” rating to a “hold” rating in a research... 
 

John Wood Group (LON:WG) Rating Lowered to Add at Numis Securities

Numis Securities lowered shares of John Wood Group (LON:WG) to an add rating in a research report report published on Tuesday, November 14th. They currently have GBX 820 ($10.98) price objective on the stock. A number of other research analysts also recently commented on WG. Credit Suisse Group reaffirmed an outperform rating and set a GBX 875 ($11.72) price objective on shares of John Wood Group in a research report on Thursday, October 26th. Barclays reaffirmed an underweight rating and set a GBX 730 ($9.78) price objective on shares of John... 
 

Vesuvius (LON:VSVS) Receives “Buy” Rating from Numis Securities

Numis Securities reaffirmed their buy rating on shares of Vesuvius (LON:VSVS) in a research report report published on Tuesday, November 14th. They currently have a GBX 730 ($9.78) price objective on the stock. A number of other research analysts also recently commented on VSVS. Peel Hunt reaffirmed a buy rating and set a GBX 740 ($9.91) price objective on shares of Vesuvius in a research report on Tuesday, November 14th. Deutsche Bank reaffirmed a hold rating and set a GBX 550 ($7.37) price objective on shares of Vesuvius in a research report... 
 

Chatham Lodging Trust (NYSE:CLDT) Lowered to “Sell” at Zacks Investment Research

Zacks Investment Research downgraded shares of Chatham Lodging Trust (NYSE:CLDT) from a buy rating to a sell rating in a research note released on Tuesday, November 14th. According to Zacks, “Chatham Lodging Trust is a self-advised hotel REIT, formed to invest in premium-branded upscale extended-stay and select-service hotels. The Company intends to invest primarily in hotels in large metropolitan markets in the United States. Chatham Lodging Trust expects that a significant portion of its portfolio will consist of hotels in the upscale extended-stay... 
 

Numis Securities Reaffirms Add Rating for Electrocomponents (LON:ECM)

Electrocomponents (LON:ECM)‘s stock had its “add” rating reiterated by research analysts at Numis Securities in a research note issued to investors on Tuesday, November 14th. They currently have a GBX 705 ($9.44) price objective on the stock. Numis Securities’ target price indicates a potential upside of 14.45% from the stock’s previous close. Several other brokerages have also recently commented on ECM. Credit Suisse Group upped their target price on shares of Electrocomponents from GBX 520 ($6.96) to GBX 575 ($7.70)... 
 

Helical’s (LON:HLCL) Buy Rating Reiterated at Numis Securities

Helical (LON:HLCL)‘s stock had its “buy” rating reaffirmed by stock analysts at Numis Securities in a research report issued to clients and investors on Tuesday, November 14th. They presently have a GBX 469 ($6.28) price objective on the stock. Numis Securities’ price target indicates a potential upside of 56.32% from the stock’s current price. Separately, Peel Hunt restated an “add” rating and issued a GBX 350 ($4.69) price objective on shares of Helical in a research report on Tuesday, November 14th. Helical... 
 

Intermediate Capital Group’s (LON:ICP) Add Rating Reiterated at Numis Securities

Numis Securities reissued their add rating on shares of Intermediate Capital Group (LON:ICP) in a research report released on Tuesday, November 14th. They currently have a GBX 967 ($12.95) price target on the stock. Other research analysts also recently issued reports about the company. Liberum Capital reissued a buy rating and issued a GBX 1,010 ($13.53) target price on shares of Intermediate Capital Group in a report on Tuesday, November 14th. Jefferies Group reissued a buy rating and issued a GBX 1,023 ($13.70) target price on shares of Intermediate... 
 

HC Wainwright Reiterates Buy Rating for TG Therapeutics (NASDAQ:TGTX)

HC Wainwright reiterated their buy rating on shares of TG Therapeutics (NASDAQ:TGTX) in a research report report published on Tuesday, November 14th, MarketBeat reports. HC Wainwright currently has a $33.00 price target on the biopharmaceutical company’s stock, up from their prior price target of $18.00. Several other equities analysts have also weighed in on the company. ValuEngine lowered TG Therapeutics from a hold rating to a sell rating in a report on Monday, October 16th. SunTrust Banks reiterated a buy rating and issued a $28.00 price... 
 

WesBanco (NASDAQ:WSBC) Given “Hold” Rating at Boenning Scattergood

WesBanco (NASDAQ:WSBC)‘s stock had its “hold” rating reiterated by Boenning Scattergood in a report issued on Tuesday, November 14th. Boenning Scattergood also issued estimates for WesBanco’s Q4 2017 earnings at $0.65 EPS, Q3 2018 earnings at $0.67 EPS, Q4 2018 earnings at $0.71 EPS and FY2018 earnings at $2.70 EPS. Several other research firms have also issued reports on WSBC. Zacks Investment Research lowered shares of WesBanco from a “buy” rating to a “hold” rating in a research report on Tuesday,... 
 

Royal Bank Of Canada Raises QUALCOMM (NASDAQ:QCOM) Price Target to $77.00

QUALCOMM (NASDAQ:QCOM) had its price target boosted by equities research analysts at Royal Bank Of Canada from $70.00 to $77.00 in a report released on Tuesday, November 14th, Marketbeat.com reports. The firm presently has an “outperform” rating on the wireless technology company’s stock. Royal Bank Of Canada’s price target would suggest a potential upside of 17.58% from the stock’s previous close. Several other research analysts have also commented on the company. Vetr raised QUALCOMM from a “hold” rating... 
 

Needham & Company LLC Cuts Everspin Tech (NASDAQ:MRAM) Price Target to $17.00

Everspin Tech (NASDAQ:MRAM) had its target price reduced by stock analysts at Needham & Company LLC from $24.00 to $17.00 in a research report issued on Tuesday, November 14th, Marketbeat.com reports. The firm presently has a “strong-buy” rating on the business services provider’s stock. Needham & Company LLC’s price target would indicate a potential upside of 119.64% from the company’s current price. MRAM has been the topic of a number of other reports. Zacks Investment Research raised Everspin Tech from... 
 

Beigene (NASDAQ:BGNE) Stock Rating Reaffirmed by Robert W. Baird

Beigene (NASDAQ:BGNE)‘s stock had its “neutral” rating reiterated by Robert W. Baird in a report issued on Tuesday, November 14th, MarketBeat.com reports. They presently have a $83.00 price target on the stock, up from their prior price target of $58.00. Robert W. Baird’s price objective points to a potential upside of 2.47% from the stock’s previous close. A number of other brokerages have also weighed in on BGNE. Ladenburg Thalmann Financial Services started coverage on shares of Beigene in a research report on Monday,... 
 

Biocept (NASDAQ:BIOC) Given “Buy” Rating at Chardan Capital

Chardan Capital reaffirmed their buy rating on shares of Biocept (NASDAQ:BIOC) in a research report report published on Tuesday, November 14th, Marketbeat.com reports. They currently have a $1.50 price target on the medical research company’s stock, down from their prior price target of $2.50. Several other research firms also recently commented on BIOC. ValuEngine raised shares of Biocept from a strong sell rating to a sell rating in a research report on Monday, October 16th. Zacks Investment Research raised shares of Biocept from a sell... 
 

Lam Research (NASDAQ:LRCX) Stock Rating Reaffirmed by B. Riley

B. Riley reissued their buy rating on shares of Lam Research (NASDAQ:LRCX) in a research note released on Tuesday, November 14th. The brokerage currently has a $250.00 target price on the semiconductor company’s stock. Several other research firms have also issued reports on LRCX. Morgan Stanley reiterated an overweight rating and set a $176.00 price target on shares of Lam Research in a research report on Monday, August 14th. Vetr lowered shares of Lam Research from a buy rating to a hold rating and set a $196.77 price target on the stock.... 
 

TJX Companies (NYSE:TJX) Given a $76.00 Price Target by Wells Fargo & Company Analysts

Wells Fargo & Company set a $76.00 price target on TJX Companies (NYSE:TJX) in a research report sent to investors on Tuesday, November 14th. The brokerage currently has a buy rating on the apparel and home fashions retailer’s stock. Several other research firms have also issued reports on TJX. Zacks Investment Research upgraded shares of TJX Companies from a hold rating to a buy rating and set a $82.00 price target on the stock in a research report on Tuesday, October 10th. Credit Suisse Group set a $72.00 target price on shares of... 
 

Cascadian Therapeutics (CASC) Rating Lowered to Hold at Zacks Investment Research

Zacks Investment Research lowered shares of Cascadian Therapeutics (NASDAQ:CASC) from a buy rating to a hold rating in a research note released on Tuesday, November 14th. According to Zacks, “Cascadian Therapeutics, Inc. is a biopharmaceutical company specializing in developing innovative therapeutic product candidates for the treatment of cancer. The company’s product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor which is in preclinical trial stage. Cascadian Therapeutics, Inc., formerly known as... 
 

Tutor Perini (NYSE:TPC) PT Lowered to $35.00

Tutor Perini (NYSE:TPC) had its price target dropped by investment analysts at B. Riley from $37.00 to $35.00 in a report released on Tuesday, November 14th, Marketbeat reports. The firm presently has a “buy” rating on the construction company’s stock. B. Riley’s target price points to a potential upside of 39.44% from the stock’s current price. B. Riley also issued estimates for Tutor Perini’s Q4 2017 earnings at $0.54 EPS, FY2017 earnings at $1.87 EPS and FY2018 earnings at $2.50 EPS. Several other research... 
 

CASI Pharmaceuticals (NASDAQ:CASI) Given a $4.00 Price Target at Maxim Group

CASI Pharmaceuticals (NASDAQ:CASI) has been given a $4.00 price target by investment analysts at Maxim Group in a report released on Tuesday, November 14th. The firm presently has a “buy” rating on the biotechnology company’s stock. Maxim Group’s target price suggests a potential upside of 10.19% from the stock’s previous close. The analysts wrote, “CASI Pharmaceuticals reported 3Q17 with a net loss of $1.6M and ended the period with $21.6M in cash. The company completed an equity financing in October, raising... 
 

Advanced Micro Devices (NASDAQ:AMD) Given “Buy” Rating at Bank of America

Bank of America reissued their buy rating on shares of Advanced Micro Devices (NASDAQ:AMD) in a research note released on Tuesday, November 14th. The brokerage currently has a $18.00 target price on the semiconductor manufacturer’s stock. Several other research analysts have also recently commented on AMD. Canaccord Genuity reaffirmed a buy rating and set a $20.00 target price on shares of Advanced Micro Devices in a report on Monday, July 17th. Barclays cut shares of Advanced Micro Devices from an equal weight rating to an underweight rating... 
 

LGI Homes (NASDAQ:LGIH) Downgraded by Zacks Investment Research to Hold

LGI Homes (NASDAQ:LGIH) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday, November 14th. According to Zacks, “LGI Homes, Inc. is engaged in the design and construction of entry-level homes across Texas, Arizona, Florida and Georgia. The company focuses on converting renters of apartments and single-family homes into homeowners by offering homes at affordable locations. LGI Homes, Inc. is headquartered in The Woodlands, Texas. “ A number of other... 
 

Zacks Investment Research Lowers Invacare (NYSE:IVC) to Sell

Zacks Investment Research lowered shares of Invacare (NYSE:IVC) from a hold rating to a sell rating in a research report report published on Tuesday, November 14th. According to Zacks, “Invacare Corporation is the world’s leading manufacturer and distributor of non-acute health care products based upon its distribution channels, the breadth of its product line and sales. The company designs, manufactures and distributes an extensive line of health care products for the non-acute care environment including the home health care, retail... 
 

Lannett (NYSE:LCI) Rating Lowered to Hold at Zacks Investment Research

Lannett (NYSE:LCI) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday, November 14th. According to Zacks, “Lannett, Inc. manufactures and distributes pharmaceutical products sold under generic names and historically has manufactured and distributed pharmaceutical products sold under its trade or brand names. In addition, the Company contract manufactures and private labels pharmaceutical products for other companies. “ Other research... 
 

Taylor Wimpey (LON:TW) Given Hold Rating at Shore Capital

Taylor Wimpey (LON:TW)‘s stock had its “hold” rating restated by Shore Capital in a note issued to investors on Tuesday, November 14th, StockTargetPrices.com reports. Other equities research analysts have also issued reports about the company. Barclays lowered Taylor Wimpey to an “equal weight” rating and set a GBX 208 ($2.79) target price on the stock. in a research report on Monday, October 30th. Deutsche Bank reaffirmed a “buy” rating and issued a GBX 243 ($3.25) target price on shares of Taylor Wimpey... 
 

ValuEngine Downgrades Delcath Systems (OTCMKTS:DCTHD) to Sell

Delcath Systems (OTCMKTS:DCTHD) was downgraded by stock analysts at ValuEngine from a “hold” rating to a “sell” rating in a research report issued on Tuesday, November 14th. Shares of Delcath Systems (OTCMKTS:DCTHD) traded down $0.03 during mid-day trading on Tuesday, reaching $0.09. The company had a trading volume of 7,598,600 shares, compared to its average volume of 1,829,448. Delcath Systems has a fifty-two week low of $0.06 and a fifty-two week high of $737.22. An institutional investor recently raised its position... 
 

Wedbush Reaffirms Neutral Rating for FireEye (NASDAQ:FEYE)

Wedbush restated their neutral rating on shares of FireEye (NASDAQ:FEYE) in a research note issued to investors on Tuesday, November 14th. They currently have a $14.00 price objective on the information security company’s stock. Wedbush also issued estimates for FireEye’s Q4 2017 earnings at ($0.24) EPS, FY2017 earnings at ($1.12) EPS, Q1 2018 earnings at ($0.27) EPS, Q3 2018 earnings at ($0.22) EPS, Q4 2018 earnings at ($0.19) EPS and FY2018 earnings at ($0.93) EPS. Several other equities research analysts also recently commented... 
 

Credit Suisse Group Lowers Esure Group (LON:ESUR) Price Target to GBX 290

Esure Group (LON:ESUR) had its price target decreased by Credit Suisse Group from GBX 315 ($4.22) to GBX 290 ($3.88) in a research report released on Tuesday, November 14th, MarketBeat reports. Credit Suisse Group currently has a neutral rating on the stock. Several other research firms have also recently commented on ESUR. Deutsche Bank restated a buy rating and issued a GBX 315 ($4.22) price target on shares of Esure Group in a report on Friday, September 8th. reissued a buy rating on shares of Esure Group in a research report on Thursday,... 
 

NEX Group (LON:NXG) Research Coverage Started at J P Morgan Chase & Co

Research analysts at J P Morgan Chase & Co began coverage on shares of NEX Group (LON:NXG) in a research report issued on Tuesday, November 14th. The brokerage set a “neutral” rating and a GBX 650 ($8.70) price target on the stock. J P Morgan Chase & Co’s price target would indicate a potential upside of 9.61% from the company’s previous close. Several other brokerages also recently weighed in on NXG. BNP Paribas reissued a “neutral” rating and issued a GBX 620 ($8.30) target price on shares of NEX... 
 
© 2006-2017 BBNS.